Literature DB >> 7463046

Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.

J E Leysen, W Gommeren.   

Abstract

I. Binding of [3H] apomorphine to dopaminergic receptors in rat striatum was most reproducible and clearly detectable when incubations were run at 25 degrees C in Tris-HCl buffer, pH 7.5, containing 1 mM-EDTA and 0.01% ascorbic acid, using a washed total-membrane fraction. The receptor binding was stereospecifically inhibited by (+)-butaclamol, and dopamine agonists and antagonists showed high binding affinity for these sites. Unlabelled apomorphine inhibited an additional nonstereospecific binding site, which was unrelated to dopamine receptors. EDTA in the incubation mixture considerably lowered nonstereospecific [3H]apomorphine binding, apparently by preventing the complexation of the catechol moiety with metal ions which were demonstrated in membrane preparations. Stereospecific [3H]apomorphine binding was not detectable in the frontal cortex, whereas in the absence of EDTA much saturable nonstereospecific binding occurred. II. Kinetic patterns of stereospecific [3H]spiperone and [3H]apomorphine binding to rat striatal membranes and the inhibition patterns of a dopamine antagonist and an agonist were evaluated at different temperatures in high-ionic-strength Tris buffer with salts added and low-ionic-strength Tris buffer with EDTA. Apparent KD values of spiperone decreased with decreasing tissue concentrations. KD values of both spiperone and apomorphine were little influenced by temperature changes. Scatchard plots of the stereospecific binding changed from linear to curved; the amount of nonstereospecific binding of the 3H ligands varied considerably, but in opposite directions for spiperone and apomorphine in the different buffers. In various assay conditions, interactions between agonists, and between antagonists, appeared fully competitive, but agonist-antagonist interactions were of mixed type. The anomalous binding patterns are interpreted in terms of surface phenomena occurring upon reactions of a ligand with complex physicochemical properties and nonsolubilized sites on membranes suspended in a buffered aqueous solution. It is concluded that anomalous binding patterns are not necessarily an indication of binding to multiple sites or involvement of distinct receptors for high-affinity agonist and antagonist binding.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7463046     DOI: 10.1111/j.1471-4159.1981.tb02396.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  13 in total

Review 1.  Recent advances in receptor research.

Authors:  M Schachter
Journal:  Postgrad Med J       Date:  1989-09       Impact factor: 2.401

2.  Lack of effect of chronic desipramine treatment on dopaminergic activity in the nucleus accumbens of the rat.

Authors:  L Reyneke; R Allin; V A Russell; J J Taljaard
Journal:  Neurochem Res       Date:  1989-07       Impact factor: 3.996

3.  [3H]205-501, a non-catechol dopaminergic agonist, labels selectively and with high affinity dopamine D2 receptors.

Authors:  A Closse; W Frick; R Markstein; R Maurer; R Nordmann
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

4.  Comparison of in vitro binding properties of a series of dopamine antagonists and agonists for cloned human dopamine D2S and D2L receptors and for D2 receptors in rat striatal and mesolimbic tissues, using [125I] 2'-iodospiperone.

Authors:  J E Leysen; W Gommeren; J Mertens; W H Luyten; P J Pauwels; M Ewert; P Seeburg
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Mesolimbic dopamine function is not altered during continuous chronic treatment of rats with typical or atypical neuroleptic drugs.

Authors:  N M Rupniak; M D Hall; E Kelly; S Fleminger; G Kilpatrick; P Jenner; C D Marsden
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

6.  Regional distribution of monoamines and dopamine D1- and D2-receptors in the striatum of the rat.

Authors:  V A Russell; R Allin; M C Lamm; J J Taljaard
Journal:  Neurochem Res       Date:  1992-04       Impact factor: 3.996

7.  Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat.

Authors:  M D Hall; P Jenner; E Kelly; C D Marsden
Journal:  Br J Pharmacol       Date:  1983-06       Impact factor: 8.739

8.  Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.

Authors:  N M Rupniak; G Kilpatrick; M D Hall; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat.

Authors:  N M Rupniak; S Mann; M D Hall; S Fleminger; G Kilpatrick; P Jenner; C D Marsden
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

10.  Effects of the putative D-1 antagonist SCH 23390 on stereotyped behaviour induced by the D-2 agonist RU24213.

Authors:  M T Pugh; K M O'Boyle; A G Molloy; J L Waddington
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.